Literature DB >> 9375844

Composition of cartilagenous tissue with mineralized and non-mineralized zones formed in vitro.

H Yu1, M Grynpas, R A Kandel.   

Abstract

We have previously shown that cartilagenous tissue with both non-mineralized and mineralized zones can be formed by chondrocytes which have been selectively isolated from the deep zone of bovine articular cartilage. In this study, we quantitate proteoglycan and collagen content, calcification, tissue thickness and cellularity over a 10 week culture period in order to study matrix accumulation and tissue formation. The cartilagenous tissue cellularity and proteoglycan and collagen accumulation continued up to 8 weeks and this was paralleled by an increase in tissue thickness. The amount of mineral in the tissue as well as the amount of collagen, in contrast to proteoglycan, was still increasing at 10 weeks. At the end of week 10, the amount of glycosaminoglycan and collagen as a percentage of dry weight of the tissue were 11.0 +/- 0.6% and 14.8 +/- 0.1%, respectively, compared with 10.5 +/- 1.2% and 35.1 +/- 5.8% for the in vitro deep articular cartilage. The amount of calcium as a percentage of dry weight of the cartilagenous tissue was 8.1 +/- 0.7% which was similar to the in vivo cartilage (9.1 +/- 1.6%). This data suggests that 8 weeks of culture may be necessary before the cartilagenous tissue is suitable for use as a transplant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375844     DOI: 10.1016/s0142-9612(97)00071-9

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  Culture of primary bovine chondrocytes on a continuously expanding surface inhibits dedifferentiation.

Authors:  Derek H Rosenzweig; Mourad Matmati; Ghazaleh Khayat; Sidharth Chaudhry; Boris Hinz; Thomas M Quinn
Journal:  Tissue Eng Part A       Date:  2012-08-03       Impact factor: 3.845

2.  Tumor necrosis factor alpha-dependent proinflammatory gene induction is inhibited by cyclic tensile strain in articular chondrocytes in vitro.

Authors:  P Long; R Gassner; S Agarwal
Journal:  Arthritis Rheum       Date:  2001-10

3.  Building an anisotropic meniscus with zonal variations.

Authors:  Michael M Higashioka; Justin A Chen; Jerry C Hu; Kyriacos A Athanasiou
Journal:  Tissue Eng Part A       Date:  2013-10-10       Impact factor: 3.845

4.  The role of tissue engineering in articular cartilage repair and regeneration.

Authors:  Lijie Zhang; Jerry Hu; Kyriacos A Athanasiou
Journal:  Crit Rev Biomed Eng       Date:  2009

Review 5.  Tissue engineering strategies for the regeneration of orthopedic interfaces.

Authors:  Helen H Lu; Siddarth D Subramony; Margaret K Boushell; Xinzhi Zhang
Journal:  Ann Biomed Eng       Date:  2010-04-27       Impact factor: 3.934

6.  Cyclic tensile stress exerts antiinflammatory actions on chondrocytes by inhibiting inducible nitric oxide synthase.

Authors:  R Gassner; M J Buckley; H Georgescu; R Studer; M Stefanovich-Racic; N P Piesco; C H Evans; S Agarwal
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

7.  Mesenchymal Stem Cells for Osteochondral Tissue Engineering.

Authors:  Johnathan Ng; Jonathan Bernhard; Gordana Vunjak-Novakovic
Journal:  Methods Mol Biol       Date:  2016

8.  Cyclic tensile strain suppresses catabolic effects of interleukin-1beta in fibrochondrocytes from the temporomandibular joint.

Authors:  S Agarwal; P Long; R Gassner; N P Piesco; M J Buckley
Journal:  Arthritis Rheum       Date:  2001-03

9.  A comparison of self-assembly and hydrogel encapsulation as a means to engineer functional cartilaginous grafts using culture expanded chondrocytes.

Authors:  Tariq Mesallati; Conor T Buckley; Daniel J Kelly
Journal:  Tissue Eng Part C Methods       Date:  2013-07-12       Impact factor: 3.056

Review 10.  Tissue engineering of articular cartilage with biomimetic zones.

Authors:  Travis J Klein; Jos Malda; Robert L Sah; Dietmar W Hutmacher
Journal:  Tissue Eng Part B Rev       Date:  2009-06       Impact factor: 6.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.